欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2018, Vol. 23 ›› Issue (10): 1103-1108.doi: 10.12092/j.issn.1009-2501.2018.10.004

• 基础研究 • 上一篇    下一篇

华蟾素对肺癌NCI-A549移植瘤裸鼠的抑制作用及机制研究

熊 飞1,施嫣嫣2,沈久成1,程洪兰1,杭永付3   

  1. 1苏州大学附属第二医院,苏州 215000,江苏; 2苏州市中医医院,苏州 215000,江苏;3苏州大学附属第一医院,苏州 215000,江苏
  • 收稿日期:2018-06-06 修回日期:2018-08-08 出版日期:2018-10-26 发布日期:2018-10-25
  • 作者简介:熊飞,男,硕士研究生,助理研究员,研究方向:中药抗肺癌的机制研究。 Tel:0512-67783745 E-mail:xf123456.cool@163.com 施嫣嫣,女,硕士研究生,主管中药师,研究方向:中药炮制。 Tel:0512-67872181 E-mail:syynjtcm@163.com
  • 基金资助:

    国家自然科学基金青年项目(81402830)

Inhibitory effect and mechanism of cinobufotalin on lung cancer NCI-A549 xenograft in nude mice

XIONG Fei 1, SHI Yanyan 2, SHEN Jiucheng 1, CHENG Honglan 1, HANG Yongfu 3   

  1. 1 The Second Affiliated Hospital of Soochow University, Suzhou 215000, Jiangsu, China; 2 Suzhou Hospital of Traditional Chinese Medicine, Suzhou 215000, Jiangsu, China; 3 The First Affiliated Hospital of Soochow University, Suzhou 215000, Jiangsu, China
  • Received:2018-06-06 Revised:2018-08-08 Online:2018-10-26 Published:2018-10-25

摘要:

目的: 研究华蟾素抗肺癌细胞NCI-A549的抗肿瘤活性及机制。方法: 40只小鼠被随机分为4组:正常组、模型组、华蟾素组和顺铂组,检测各组小鼠的体质量变化、抑瘤率、血液和肝肾功能,应用Western blot分析凋亡相关蛋白表达情况。结果: 华蟾素可显著抑制A549移植瘤的生长,对小鼠血液及肝肾功能无明显影响,各组抑瘤率分别为58.0%和82.3%,Western blot结果显示华蟾素可以显著上调Bax/Bcl-2的表达,促进cleaved-Casp3和cleaved-PARP的表达并抑制p-AKT(ser473)的表达。结论: 华蟾素可以显著抑制肺癌A549移植瘤的生长,其分子机制可能与抑制PI3K/AKT通路的活化,从而促进肿瘤细胞凋亡相关。

关键词: 华蟾素, 肺癌, 移植瘤, 凋亡, PI3K/AKT通路

Abstract:

AIM: To investigate the anti-tumor effect and mechanism of cinobufotalin on lung cancer cells NCI-A549.  METHODS: Forty BALB/c nude mice were randomly divided into the normal group, the mock group, the cinobufotalin group and the DDP (cisplatin) group. Body weight change, tumor inhibition rate, blood function, liver and kidney function of the mice in each group were detected. Western blot was used to investigate the expression of apoptosis-associated proteins.RESULTS:Cinobufotalin significantly inhibited the growth of A549 xenograft, but had no significant effect on the blood, liver and kidney function of the mice. The tumor-inhibition rate of the cinobufotalin group and the DDP group was 58.0% and 82.3%, respectively. Western blot results showed that cinobufotalin significantly up-regulated the expression of Bax/Bcl-2, promoted the expression of cleaved-caspase-3, cleaved-PARP, and inhibited the expression of p-AKT(ser473). CONCLUSION: Cinobufotalin can significantly inhibit the growth of lung cancer A549 xenograft. Its molecular mechanism might be related to the inhibition of PI3K/AKT pathway activation. Based on this mechanism, cinobufotalin can accelerate cell apoptosis.

Key words: cinobufotalin, lung cancer, xenograft, apoptosis, PI3K/AKT pathway

中图分类号: